Trump ad­min­is­tra­tion preps ex­ec­u­tive or­der on price trans­paren­cy as law­mak­ers con­verge — WSJ

In a po­lit­i­cal sphere where Re­pub­li­cans and De­moc­rats can find lit­tle com­mon ground, the phar­ma in­dus­try in gen­er­al — and price trans­paren­cy in par­tic­u­lar — has pre­sent­ed a rare op­por­tu­ni­ty for bi­par­ti­san agree­ment.

A slew of trans­paren­cy bills are wind­ing their way through con­gres­sion­al cir­cles, with au­thors from both sides of the po­lit­i­cal aisles. And now the Wall Street Jour­nal re­ports that phar­ma Crit­ic-in-Chief Don­ald Trump is prep­ping an ex­ec­u­tive or­der that would re­quire that con­sumers have ac­cess to the rates that have been ne­go­ti­at­ed through­out the sys­tem.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.